RECURSION PHARMACEUTICALS, INC.

RXRX Nasdaq CIK: 0001601830

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
Mailing Address 41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
Phone (385) 269-0203
Fiscal Year End 1231
EIN 464099738

Financial Overview

FY2024

-$239.48M
Net Income
$1.45B
Total Assets
$413.82M
Total Liabilities
$594.35M
Cash & Equivalents
$-1.36
EPS

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report February 10, 2026 View on SEC
4 Insider stock transaction report February 10, 2026 View on SEC
4 Insider stock transaction report February 10, 2026 View on SEC
4 Insider stock transaction report February 6, 2026 View on SEC
4 Insider stock transaction report February 6, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 5, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 3, 2026 View on SEC
4 Insider stock transaction report January 22, 2026 View on SEC
8-K Current report of material events January 12, 2026 View on SEC
3 Initial insider ownership report January 9, 2026 View on SEC

Insider Trading

STRONG SELL 4 insiders 11 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.